09/12/2021
The Omicron variant can partially evade protection from two doses of Pfizer (PFE.N) and partner BioNTech’s COVID-19 vaccine, the against research head of a laboratory at the Africa Health Research Institute in South Africa said on Tuesday. But the study showed that blood from people who had received two doses of the vaccine and had a prior infection was mostly able to neutralize the variant, suggesting that booster doses of the vaccine could help to fend off infection....